Enzyme immunoassay for the quantitative determination of denosumab (Prolia®) in serum and plasma.
Matriks Biotek denosumab ELISA has been especially developed for the quantitative analysis of denosumab in serum and plasma samples between the Cmin and Cmax range of concentrations indicated in the pharmacokinetics section of prospectus.
|Required Volume (µl)||10|
|Total Time (min)||70|
|Dedection Limit (ng/mL)||0,001|
|Spike Recovery (%)||97|
|Shelf Life (year)||1|